China Market Intelligence

April 22nd, 2020
Melinda Xu

Earlier this month, the Chinese government tightened rules for exports of certain medical products used to combat COVID-19 in response to high-profile complaints about their quality. In light of these new requirements, exporters and importers of these goods can expect that the customs process will be delayed.

August 7th, 2019
By USCBC Staff

On July 31, US-China Business Council (USCBC) President Craig Allen testified before the US-China Economic Security Review Commission (USCC) on US companies’ access, risks, and opportunities in China’s health market.

February 27th, 2019
By USCBC Staff
The 13th National People’s Congress (NPC) kicks-off in Beijing on March 5. Convening just after trade negotiations were extended, it will be important to watch how China’s government deals with key issues such as the Foreign Investment Law, which is expected to pass.
January 16th, 2019
By Chynna Hawes

Draft amendments make some progress in strengthening China’s intellectual property rights (IPR) system, including by increasing penalties, extending patent term for designs, and adding patent term restoration for innovative pharmaceuticals.

September 20th, 2018
By Chynna Hawes

On September 7, the 13th National People’s Congress Standing Committee (NPCSC), China’s constitutional authority, released its five-year legislative plan, outlining and prioritizing major legislative tasks into three classes that, in princi

September 20th, 2018
By Chynna Hawes

China’s regulators recently released the first drug traceability proposal since China suspended its previous system in 2016 because of a number of 

August 8th, 2018
By Chynna Hawes

The Shanghai Free Trade Zone (FTZ) Market Regulatory Authority (MRA) recently issued a penalty decision against a foreign medical product distributor for false promotion under the Anti-unfair Competition Law (AUCL), the revised version of which came into effect January 1.

July 11th, 2018
By Ricky Altieri

China has implemented new rules setting requirements on the storage, use, and flow of scientific data. Although intended to strengthen data security and promote data sharing, the measures could affect companies’ university partnerships and R&D centers in the pharmaceutical, automotive and tech industries.

June 27th, 2018
By Anna Ashton

US companies now have stronger recourse against Chinese businesses that claim Chinese law as a protection for unfair practices.

February 7th, 2018
By David Solomon

China’s National Development and Reform Commission (NDRC) recently announced its 2018 priorities for pricing investigations under the anti-monopoly law (AML), listing key industries in which it says price-fixing tactics

Pages

Phase One Tracker

We are tracking over 150 commitments—several of which had never been offered before—on items ranging from market access to improving intellectual property rights protection and administrative reforms. 

LEARN MORE